PRJNA663223
FUSCC-PCMC BRCA target sequencing
Remarkable advances in next-generation sequencing technology enable the wide usage of sequencing as a clinical tool. Here, we conducted a large-scale prospective clinical sequencing program using the Fudan-BC panel, and comprehensively analyzed the clinical and genomic characteristics for Chinese breast cancer. A total of 1,134 consecutive Chinese patients who were treated at the Department of Breast Surgery at Fudan University Shanghai Cancer Center (FUSCC) were enrolled in this cohort from April 1, 2018, to December 31, 2018. This submission included the data of ID 1801001 - ID 1900384.